Jenny Hao Koppelkamm
Advisor
Jenny Hao Koppelkamm
Advisor
Jenny has
over 20 years of experience in global pharma, medical devices, and
diagnostics. She has held senior positions in market access at Pfizer,
Novartis, Vifor and Takeda across the US, EU and China. Jenny is highly skilled
in pricing and reimbursement, market access, government affairs and
policy. She has led numerous projects and initiatives to support products
in different therapeutic areas through the whole lifecycle.
With a strong
passion for entrepreneurship, Jenny started consulting in 2021. She has
led and conducted multiple projects. In addition, Jenny has deep knowledge of
various healthcare systems and has established a broad network with various
stakeholders.
Jenny is
also an active business angel in healthcare start-ups, keeping up with the
latest innovations. She supports Convergence Partners, a venture capital firm
based in Zurich, in business development of its portfolio companies.
Jenny is trained as a medical doctor, graduated from Capital Medical University in Beijing, China; she received her MBA at Fairleigh Dickinson University in the US. She completed a HTA program at the European School of Health Economics and had executive courses including strategic negotiation at Harvard and other top US universities. Jenny lives in Zurich with her family.
Read more about Jenny in our Blog
Mind the communication gap in patient access
Read the story of how the clear communication unlocked the market access potential of an innovative product for our client.
Akceso’s ‘Evidence-based Asset Valuation’ methodology
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
How a hostage negotiator can inspire business leaders?
Read the thoughts of András Incze related to the Advanced High-Performance Leadership (HPL) program led by Professor George Kohlrieser.
One of the things I learnt from Akceso – always welcome challenges
One of the things that I have learnt during my time with Akceso is that, if you believe that something is good and brings value, do not wait to start doing it.
Why the World needs Catalysts?
’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.
